Product Program year 2025 Source: CMS Open Payments

Xience Skypoint

Device Vascular

PDI 08717648233678

Open in the dashboard

General payments

$269,873

4,950 payments

Research payments

$703,613

347 payments

Through program year 2025, $269,873 in general payments and $703,613 in research payments were reported against Xience Skypoint (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 Research $65,216 65
2024 General $153,333 2,612
2024 Research $286,498 134
2023 General $116,540 2,338
2023 Research $351,899 148

Breakdown

Who paid General payments · program years 2023–2024
  1. Abbott Laboratories $269,873 4,950 payments
Top recipients General payments · program year 2024
  1. Washington Hospital Center Teaching hospital · DC $25,000 16% · 1 payment
  2. Bruce Samuels Cardiovascular Disease · Beverly Hills, CA $16,583 11% · 5 payments
  3. Mun Hong Interventional Cardiology · Cooperstown, NY $13,500 9% · 10 payments
  4. Loma Linda University Medical Center Teaching hospital · CA $7,500 5% · 3 payments
  5. Steven Roh Interventional Cardiology · Minneapolis, MN $4,700 3% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Interventional Cardiology Internal Medicine $61,057 53% · 481 practitioners
  2. Cardiovascular Disease Internal Medicine $37,769 33% · 272 practitioners
  3. Internal Medicine $3,630 3% · 52 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $2,193 2% · 29 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $1,601 1% · 32 practitioners

The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $31,234 20% · 159 recipients
  2. District of Columbia $25,419 17% · 7 recipients
  3. New York $18,922 12% · 103 recipients
  4. Tennessee $7,290 5% · 51 recipients
  5. Minnesota $7,253 5% · 9 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

4,950 general · 347 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record